Advisor Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Advisor Group's GILD Position: Q4 2019 in Review
Advisor Group reduced its Gilead Sciences (GILD) stake by 9.9% in Q4 2019, selling an estimated $839K and leaving 117,270 shares worth $7.63M. The position accounts for 0.05% of the portfolio, ranked #290.
Advisor Group first reported a position in GILD in Q2 2016 and has held it in 15 quarters since. The position peaked at $14.3M in Q3 2016. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.
- Advisor Group held 117,270 shares of Gilead Sciences worth $7.63M as of Q4 2019.
- Advisor Group sold 12,880 Gilead Sciences shares in Q4 2019, an estimated $839K.
- Gilead Sciences made up 0.05% of Advisor Group's portfolio in Q4 2019, its #290 holding.
- Advisor Group first reported a position in Gilead Sciences in Q2 2016 and has held it in 15 quarters since.
- Advisor Group's Gilead Sciences position peaked at $14.3M in Q3 2016.
- 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.